Stock XOMA XOMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus XOMA Corporation

Equities

XOMA

US98419J2069

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
25.66 USD +3.84% Intraday chart for XOMA Corporation +8.32% +38.70%
May. 09 Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M MT
May. 09 XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on XOMA Corporation

Price target over the last 5 years

History of analyst recommendation changes

92bf47baa1ce67b8f1bca91f.t1wwMCF_rZMNY1WEvk79yowfrpHFulwdL9leSCQVA-w.02thVFEr49U8NRfg0hunnNZRwtqv4x9Wf4E6GXIsdYDUa3xgdhXawXsaDA~2e67972e63865326b34cacad2c5259ee

Analyst Recommendations on XOMA Corporation

Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target MT
HC Wainwright Adjusts Price Target on XOMA to $74 From $69, Maintains Buy Rating MT
XOMA : Wedbush Suspended Coverage on XOMA MT
XOMA : HC Wainwright Adjusts XOMA's Price Target to $69 from $56, Keeps Buy Rating MT
XOMA : Aegis Capital Adjusts XOMA Price Target to $56 From $60, Maintains Buy Rating MT
Wedbush Downgrades XOMA to Neutral From Outperform, Adjusts PT to $22 From $41 MT
XOMA : Wedbush Downgrades XOMA to Neutral From Outperform, Adjusts PT to $22 From $41 MT
XOMA : Aegis Capital Starts XOMA at Buy with $20.68 Price Target MT
XOMA : Wedbush Adjusts XOMA's Price Target to $41 From $36, Citing Iscalimab, Cetrelimab Projections; Outperform Rating Kept MT
XOMA : Wedbush Adjusts XOMA's Price Target to $36 From $29 on Vicineum Sales Forecast, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
25.66 USD
Average target price
58 USD
Spread / Average Target
+126.03%
High Price Target
74 USD
Spread / Highest target
+188.39%
Low Price Target
42 USD
Spread / Lowest Target
+63.68%

Consensus detail

Consensus revision (last 18 months)

Analysts covering XOMA Corporation

Leerink Partners
HC Wainwright
Wedbush
Aegis Capital

Ratings for XOMA Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. XOMA Stock
  4. Consensus XOMA Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW